FIELD: biotechnology, pharmacology and medicine.
SUBSTANCE: invention relates to biotechnology, pharmacology and medicine. The use of lipopolysaccharide produced by a strain of phototrophic bacterium Rhodobacter capsulatus PG RNCIM IBFM RAS V-2381D as a non-toxic blocking factor protecting against the effects of lipoteichoic acids, Toll-like receptor 2 agonists.
EFFECT: invention provides for expanding the range of drugs based on non-toxic lipopolysaccharide produced by a strain of phototrophic bacterium Rhodobacter capsulatus PG for blocking the activation of intracellular signaling pathways by TLR2 ligands and the synthesis of pro-inflammatory cytokines by immune cells.
1 cl, 6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-ALLERGIC AGENTS | 2017 |
|
RU2690430C2 |
| APPLICATION OF PHOTOTROPHIC BACTERIA RHODOBACTER CAPSULATUS PG LIPOPOLISACCHARIDE AS FACTOR AFFECTING DIFFERENTIATION ACTIVITY OF 1ALFA,25-DIHYDROXYVITAMIN D3 | 2016 |
|
RU2642309C1 |
| AGENT FOR DIFFERENTIATION OF MONOCYTE-LIKE CELLS | 2014 |
|
RU2590696C2 |
| STRAIN OF RHODOBACTER CAPSULATUS PG - PRODUCER OF LIPOPOLYSSACHARIDE, ENDOTOXIN ANTAGONIST | 2008 |
|
RU2392309C1 |
| MULTICOMPONENT VACCINE FOR IMMUNOPROPHYLAXIS AND IMMUNOTHERAPY OF DISEASES CAUSED BY OPPORTUNISTIC PATHOGENS | 2022 |
|
RU2786222C1 |
| METHOD OF ALTERING IMMUNOMODULATING PROPERTIES OF LIPOPOLYSACCHARIDES OF PLAGUE BACTERIA IN VITRO | 2011 |
|
RU2489755C1 |
| USE OF A SYMBIOTIC CONSORTIUM OF PROBIOTIC LACTOBACILLI STRAINS ISOLATED FROM HUMAN MILK, WHICH HAS A BACTERICIDAL EFFECT ON MASTITIS-INDUCING PATHOGENS, FOR THE MANUFACTURE OF DRUGS FOR THE COMPLEX PREVENTION AND TREATMENT OF LACTATIONAL MASTITIS | 2022 |
|
RU2801119C1 |
| COMPOSITION FOR STIMULATING DENDRITIC CELL MATURATION, CONTAINING HYBRID PROTEIN RV2299C/ESAT-6 | 2017 |
|
RU2733886C2 |
| METHOD FOR IDENTIFYING FUNCTIONAL M1 AND M2 PHENOTYPE OF HUMAN MACROPHAGES GENERATED IN VITRO FROM BLOOD MONOCYTES | 2019 |
|
RU2717024C1 |
| METHOD OF IMMUNOTHERAPY OF PURULENT RHINOSINUSITIS | 2010 |
|
RU2457789C2 |
